The Playboy Drug Panel that Predicted the Next Fifty Years
The Playboy Drug Panel that Predicted the Next Fifty Years
In February 1970, before the phrase “war on drugs” had fully hardened into national policy, Playboy published a strange, fascinating, and almost forgotten roundtable called “The Drug Revolution.”
On paper, it sounds like a fever dream: William S. Burroughs, Harry Anslinger, James Coburn, Baba Ram Dass, Leslie Fiedler, John Finlator, Joel Fort, Joseph Oteri, and Alan Watts, all gathered under the glossy umbrella of Playboy to debate marijuana, heroin, LSD, medicine, policing, freedom, addiction, and the future of consciousness.
This was not some obscure mimeographed manifesto passed hand to hand in the Haight. It was Playboy, a mainstream magazine with a countercultural nervous system, placing the drug question in front of a national audience right before America would decide whether altered states belonged in hospitals, temples, laboratories, prisons, or the hands of the people themselves.
Reading it now feels less like entering a time capsule than overhearing the first draft of an argument we still have not resolved.
The panel arrived at a hinge moment. The late sixties had turned psychedelics into both sacrament and scandal. LSD had escaped the clinic, passed through artists, students, musicians, pranksters, seekers, and casualties, and emerged as one of the most symbolically loaded substances in American life. Marijuana had become a generational dividing line. Heroin was being treated as both public health crisis and urban menace. The state was preparing to answer with classification, enforcement, surveillance, and punishment.
What makes the Playboy panel so interesting is not that everyone agreed. They absolutely did not. What makes it interesting is that nearly every modern drug-policy argument appears there in embryonic form.
Joseph Oteri argued, with striking modernity, that marijuana was relatively harmless and should be legal, while heroin addiction should be treated as sickness rather than crime. That distinction still feels radical in some rooms today: punish the dealer, treat the user, separate the substance from the person, and stop pretending the police are physicians.
Harry Anslinger, meanwhile, represented the old guard of narcotics panic. What a racist shitshow of a human being, btw. His presence alone gives the panel an almost mythic charge. Anslinger had helped build the federal anti-marijuana machine, and in the panel he reached for the familiar predictive terror: legalize marijuana, and the highways would become killing fields. It is classic prohibition rhetoric, the future imagined as catastrophe, the drug user cast as a threat before he has even acted. (He famously told the media that marijuana made Black people physically violent and invincible).
Then there is James Coburn, Hollywood star and unlikely voice of civic psychedelic governance, suggesting that perhaps decisions about psychedelics should not belong only to doctors, lawyers, or police, but to educated citizens, including artists. That line may be my fave in the whole exchange. Artists at the policy table. Imagination as a form of public safety. Culture as expertise.
And hovering over all of it are Alan Watts, Ram Dass, and Burroughs, three very different avatars of consciousness. Watts brought the philosopher’s slipperiness, Ram Dass the newly spiritualized language of inner awakening, and Burroughs the hard, cold eye of someone who understood addiction, control, and the grotesque machinery of power from the inside out.
That is what makes the panel feel so alive now; it is not merely about drugs. It is about who gets to define reality.
Is marijuana a menace, a medicine, a pleasure, a plant, a racialized fear object, a taxable commodity, a lifestyle accessory, or a civil liberty? Is LSD a psychotomimetic danger, a spiritual technology, a therapeutic catalyst, an artistic solvent, or a national security threat? Is heroin addiction a moral failure, a criminal identity, a medical condition, or a symptom of despair?
The answer, as always, depends on who is telling the story. And if you’ve been following me long enough, this is my sweet spot.
Joey Genovese`
The government told one kind of story: drugs as enemy. The counterculture told another: drugs as liberation. Doctors told one: drugs as treatment, risk, pathology, dose, and outcome. Mystics like good ol’ Ram Dass told another: drugs as doorways. Writers, naturally, complicated everything.
This is where the Playboy panel becomes more than a curiosity. It captures the precise moment before the drug conversation got flattened. Before marijuana became only a Schedule I substance. Before psychedelics were pushed out of mainstream research. Before heroin addiction became one more arena in the American punishment machine. Before “Just Say No” turned complexity into slogan.
In 1970, the story was still up for grabs.
There is something almost heartbreaking about that. You can feel alternate futures flickering inside the conversation. A future where psychedelics stayed in supervised research institutes. A future where addiction was treated as illness. A future where artists, patients, physicians, philosophers, and ordinary citizens helped shape policy together. A future where the state did not confuse control with care.
Instead, America largely chose fear. The irony, of course, is that Playboy understood something many institutions did not: drugs were not a fringe issue. They were a cultural issue. A philosophical issue. A sexual issue. A generational issue. A spiritual issue. A legal issue. A storytelling issue.
The drug debate was never just about what people put into their bodies. It was about authority over consciousness itself.
Igor Omilaev
That is why the panel still matters. We are living through another hinge moment now. Psychedelics are back in clinical trials, documentaries, investor decks, retreat centers, underground circles, policy reform campaigns, and wellness branding. Cannabis has gone from contraband to consumer product in much of the country. Ibogaine, MDMA, psilocybin, ketamine, ayahuasca, and LSD have re-entered public conversation through the languages of trauma, veterans’ care, depression, addiction, creativity, and neuroplasticity.
Once again, the story is being rewritten.
And once again, the question is not only what these substances do. The question is who gets to narrate their meaning.
The scientists? The shamans? The investors? The government? The patients? The artists? The people who survived the first drug war? The people who profited from it? The people whose communities were destroyed by it? The people now packaging transcendence in tasteful fonts?
The 1970 Playboy panel reminds us that drug history is not a straight line from ignorance to enlightenment. It is a battle of frames. Every era invents the drug story it needs. The same molecule can be cast as poison, sacrament, weapon, medicine, escape hatch, or mirror.
More than fifty years later, the panel reads like a séance. The dead arguments are not dead. The old fears are wearing new clothes. The old hopes are back too, a little more polished, a little more marketable, maybe a little more cautious.
The drug revolution never ended—it just changed narrators.
Gallery
Recent Articles
